Acne Medication Market size is estimated at USD 12.1 billion in 2024 and is set to exceed USD 23.3 billion by the end of 2037, expanding at over 5.4% CAGR during the forecast period i.e., between 2025-2037. In 2025, the industry size of acne medication is assessed at USD 12.7 billion.
The rising prevalence of acne or skin disorders such as acne, eczema, and psoriasis is the prime reason fuelling the acne medication market. A 2023 report published by the World Health Organization (WHO) stated that skin conditions are estimated to impact 1.8 billion people at any point in time.
Antibiotics, retinoids, and isotretinoin are some medications used for acne treatment, wherein antibiotics are the most used drugs for acne treatment and are expected to exhibit high global demand throughout the forecast period. According to a report by the National Center for Biotechnology Information (NCBI) published in June 2023, the prevalence of acne among teenagers worldwide is around 80%. The same source also estimates that adult acne problem affects 40% of the population.
Additionally, companies are launching new formulations that combine existing ingredients with advanced delivery systems are also driving the acne medication market. For instance, in July 2024, Crown Laboratories announced that its brand PanOxyl has come with the latest innovations in acne-banishing body spray. Body sprays formulated with 2% salicylic acid are now aiding in clearing blemishes and unclogging pores more effectively, leading to long-lasting results.
Growth Drivers
Challenges
Base Year |
2024 |
Forecast Year |
2025-2037 |
CAGR |
5.4% |
Base Year Market Size (2024) |
USD 12.1 billion |
Forecast Year Market Size (2037) |
USD 23.3 billion |
Regional Scope |
|
Product (Antibiotics, Retinoids, Isotretinoin)
Antibiotics segment is projected to account for more than 46.5% acne medication market share by the end of 2037. According to NCBI, pharmacological drugs such as antibiotics are the first line of treatment for mild to moderate-stage acne. Antibiotics effectively kill skin bacteria and reduce inflammation surrounding the affected area and are available in two forms topical and oral, wherein clindamycin and erythromycin are widely adopted topical antibiotics, and tetracyclines and macrolide are oral ones. American Academy of Dermatology (AAD) estimates that the use of topical antibiotics alongside retinoids or benzoyl peroxide in acne treatment offers effective results.
Distribution Channel (Retail and Online Pharmacies, Hospital Pharmacies)
Sales of acne medications through retail and online pharmacies in acne medication market are anticipated to rise at a high CAGR throughout the forecast period. The easy availability of over-the-counter (OTC) medications is driving the online sales of acne drugs. Patients can easily compare and buy acne OTC medications without a prescription and a direct visit to physical stores, this convenience is contributing to their online sales growth. Retail pharmacies are also equipped with advanced and latest medications, which reduces the need to visit hospital pharmacies. Furthermore, online and retail pharmacies offer various discounts and offers, which make them the most sought-after mode of distribution channel.
Our in-depth analysis of the acne medication market includes the following segments:
Product |
|
Route of Administration |
|
Age Group |
|
Distribution Channel |
|
North America Market Forecast
North America in acne medication market is projected to hold more than 48.4% revenue share by 2037. The increasing prevalence of acne and advancements in drug formulation are prime factors boosting acne medication sales in North America. According to the American Academy of Dermatology, acne is the most common skin disorder among American people, affecting around 50 million individuals annually. Around 85% of people between ages 12 and 24 experience acne-related issues once in their lifetime.
The U.S. acne medication market is foreseen to increase at a CAGR of 5.5% from 2025 to 2037. Favourable government regulations and rising patient adoption of teledermatology promote market expansion. For instance, according to data published in the Journal of the American Academy of Dermatology, teledermatology consultations reached from 263 to 21,385 annually by 2020. Furthermore, guidelines for the use of telemedicine to provide patients with high-quality treatment during the pandemic were established by the Center for Disease Control and Prevention in 2020.
In Canada, acne is also one of the major skin issues affecting many individuals, hormonal changes and heredity are some of the prime reasons responsible for acne medication market growth. According to the Canadian Dermatology Association, 5.6 million individuals in the country are living with acne issues. Moreover, several companies in the country are actively launching innovative products that are fuelling the growth of the acne medication market. For instance, in December 2022, Bausch Health Companies Inc. announced the launch of ARAZLO a topical prescription medication for acne vulgaris treatment in Canada.
APAC Market Statistics
Asia Pacific market is expected to increase at a fast pace during the forecasted period owing to the rising awareness of skincare and related products and increasing consciousness about physical appearance among youngsters and adults. Additionally, rising disposable incomes and improved healthcare infrastructure in countries such as China, India, and Japan contribute to increased spending on acne treatments.
In China, the expanding middle class and increased disposable incomes, are rising investments in healthcare and skincare products, including acne medications. Additionally, the rise in e-commerce platforms and online pharmacies has made acne medications more accessible to a broader audience, particularly in urban areas.
The acne medication market is quite competitive owing to the presence of established players and the entry of start-ups such as Stryke Club, Derm-Biome Pharmaceuticals, Legit Health, and Dermatica. The key players in the market are mainly focused on the production of advanced medications for acne care, whereas new companies on offering cutting-edge AI-based skin care solutions.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?